Advice Page

‹Return to Search Results

Drug Details

Drug Number: 481/08
Drug Name: docetaxel (Taxotere)
Drug Manufacturer: Sanofi-Aventis
BNF Category: Malignant disease and immunosuppression
Submission type : Full submission
Date Advice Issued: 07 July 2008
Indication: In combination with cisplatin and 5-fluorouracil (5-FU) is indicated for the induction treatment of patients with locally advanced squamous cell carcinoma of the head and neck

Drug Advice

docetaxel (Taxotere)

Press Statement

Read the press statement

Link opens in new windowRead the media briefing

Minutes

Read the minutes

Notes

‹Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product







Help on how to improve your search.